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ABSTRACT  1 
Background: Phase angle measured by bioelectrical impedance analysis (BIA) may be a 2 
marker of health state.  3 
Objective: This historical cohort study of prospectively collected BIA measurements aims to 4 
investigate the link between phase angle and mortality in older people and evaluate whether a 5 
phase angle cut-off can be defined. 6 
Design: We included all adults aged ≥65 years who underwent a BIA measurement by the 7 
Nutriguard® device at the Geneva University Hospitals. We retrieved retrospectively the phase 8 
angle and co-morbidities at the last BIA measurement and the mortality until December 2012. 9 
We calculated phase angle standardized for sex, age, and body mass index, using reference 10 
values determined with the same brand of BIA device. Sex-specific and standardized phase 11 
angle were categorized into quartiles. The association of mortality with sex-specific or 12 
standardized phase angle was evaluated through univariate and multivariate Cox regression 13 
models, Kaplan-Meier curves, and ROC curves.  14 
Results: We included 1307 (38% women) participants, among whom 628 (44% women) died. 15 
In a multivariate Cox regression model adjusted for co-morbidities and setting of measurement 16 
(ambulatory vs. hospitalized), the protective effect against mortality increased progressively as 17 
the standardized phase angle quartile increased (HR 0.71 (95% CI 0.58, 0.86), 0.53 (95% CI 18 
0.42, 0.67), 0.32 (95% CI 0.23, 0.43)). The discriminative value of continuous standardized 19 
phase angle, assessed as the area under the ROC curve, was 0.72 (95%CI 0.70, 0.75). We could 20 
not define an acceptable phase angle cut-off for individual prediction of mortality (LK), based 21 
on sensibility and specificity values. 22 
Conclusions: This study shows the association of phase angle and mortality in older patients, 23 
independently of age, sex, comorbidities, BMI categories, and setting of measurement. 24 
  25 
3 
Published in final edited form as: Rejuvenation Res. 2017 Apr;20(2):118-124. doi: 10.1089/rej.2016.1879 
 
INTRODUCTION 26 
Bioelectrical impedance (BIA) is widely used to assess body composition in clinical practice. 27 
BIA-derived fat free mass index has been related to mortality (1). However, it requires the use 28 
of validated population-specific equations and is inaccurate in the case of altered fluid balance, 29 
as often found in older people, body shape asymmetries, and extreme body mass indices (2).  30 
In view of these limitations, an increasing number of studies have focused on raw BIA-31 
derived electrical parameters, such as phase angle, whose accuracy does not rely on equations 32 
or anthropometrical characteristics. In BIA measurements, a generator applies an alternating 33 
electrical current to the human body. The human body presents an overall opposition to this 34 
current, termed bioelectrical impedance, consisting of two elements: the reactance which is due 35 
to the capacitance (electrostatic storage) of cellular membranes, tissue interfaces and nonionic 36 
tissues, and the resistance which refers to the pure resistive behavior of tissues due to extra- and 37 
intracellular water. In response to an alternating electrical current, the capacitance causes a time 38 
delay between the voltage waveform and the current waveform which lags behind (3,4). This 39 
time delay can be expressed in units of time, i.e., phase shift, or as a percent of the entire wave 40 
period consisting of 360 degrees, i.e., phase angle. Mathematically, the phase angle can be 41 
calculated from the arctangent of the measured reactance to resistance ratio (3). Although its 42 
metabolic significance is not yet clear, the phase angle has been reported to reflect cell 43 
membrane integrity, cell size and/or the distribution of intra- vs. extracellular water (5). 44 
A low phase angle has been shown to predict mortality in patients with critically illness (6) 45 
(7) or specific chronic diseases such as cancer (8), chronic heart failure (9), liver cirrhosis (10), 46 
HIV infection (11), amyotrophic lateral sclerosis (12), and hemodialysis (13). Thus, the phase 47 
angle may be viewed as a prognostic marker in specific diseases. However, only a few large 48 
cohort studies have evaluated the link between phase angle and mortality in polymorbid older 49 
people (14,15). These studies have found a fourfold increase in in-hospital mortality with a 50 
phase angle below 3.5° (vs. 5.0-5.5°) (14) or a twofold higher risk of 12-year mortality with a 51 
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phase angle below 5.4° in women (vs. >6.02°) and 5.6° in men (vs. >6.34°) (15). These studies 52 
confirm the association of low phase angle and high mortality, but they have found variable 53 
cut-offs, likely due to the type of BIA device used, the characteristics of the study populations 54 
and their co-morbidities, and the length of considered follow-up. 55 
We hypothesized that a low phase angle is associated with an increased mortality risk, 56 
independently of the co-morbidities and the setting of measurement, i.e. ambulatory or 57 
hospitalized. If this hypothesis was confirmed, it would suggest that phase angle could be used 58 
as a monitoring tool to evaluate the impact of therapeutic strategies, as drugs or lifestyle 59 
changes. This study aims to 1) investigate the link between phase angle and mortality in older 60 
hospitalized and ambulatory people, 2) compare the impact of phase angle vs. fat-free mass 61 
index (FFMI) on mortality, and 3) evaluate whether a phase angle cut-off value can be defined 62 
with respect to mortality.  63 
64 
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SUBJECTS AND METHODS 65 
This retrospective study includes all BIA measurements performed in people aged ≥65 years 66 
between 1990 and 2011 at the Geneva University Hospitals, either for research or clinical 67 
purpose. The indications for BIA measurements in the clinical and research settings at our 68 
hospital, the data retrieval from our hospital and research computer database, and the data 69 
merging has been detailed elsewhere (1). We included only the last available BIA measurement 70 
of each person, as it was the closest to death and thus the most likely to be associated with 71 
mortality. This protocol was accepted by the Ethical Committee of the HUG, who waived the 72 
need to obtain informed consent, and was registered under clinicaltrials.gov (NCT01472679). 73 
We chose to use phase angles measured by a single device as the values may differ between 74 
devices, precluding their use in the same database. We focused on the measurements performed 75 
with the Nutriguard® (Data Input, Pöcking, Germany) because 1) this device is being used 76 
since 2001 until now, in contrast to other devices that were used from 1990 to 2001; and 2) we 77 
could calculate a sex-, age- and body mass index (BMI)-standardized phase angle (Z-score) 78 
using the German phase angle reference values, which were measured with the same brand of 79 
BIA device (16). The following formula was used for the calculation of the Z-score: 80 
Standardized phase angle = (observed phase angle - mean reference phase angle)/SD of 81 
reference phase angle.  82 
We excluded subjects with missing height (n=4), weight (n=3), and residency abroad (n=14), 83 
as we could not retrieve their mortality data, and those who died on the day of measurement 84 
(n=143) as they are not considered in Cox regression models, and those with BIA 85 
measurements performed with another device than the Nutriguard ®  (n=1878). 86 
All the BIA measurements were performed while the person was lying in the supine position. 87 
Four electrodes were placed on the right hand, wrist, foot, and ankle and were connected to a 88 
generator applying an alternating electrical current of 0.8 mA and 50 kHz. We reported the 89 
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phase angle, impedance, resistance, and reactance and calculated the fat-free mass by our BIA 90 
formula, developed in the population of the Geneva area (17) and validated in older people 91 
against dual energy x-ray absorptiometry (18). In our routine procedure, the weight and height 92 
of the patients are measured on the same day as BIA assessments. FFMI was calculated as fat-93 
free mass (kg)/height (m)2 and BMI as weight (kg)/height (m)2. 94 
Co-morbidities and medication were retrieved, whenever available, from the computerized 95 
medical records of the Geneva University Hospitals at the time of BIA measurements and 96 
reported in the form of the Cumulative Illness Rating Scale (CIRS). This comorbidity index 97 
rates 14 organs and systems from 0 (healthy) to 4 (severe disease) by taking into account the 98 
symptoms, laboratory findings, medical history, lifestyle factors, and medications. In total, it 99 
ranges from 0 to 56 points (19,20).  100 
The date and cause of death were obtained from the computer database of the Geneva 101 
University Hospitals, the Geneva population register of deaths (21), and the Swiss National 102 
Cohort (22). The latter is a Swiss data platform linking anonymously national censuses with 103 
all-cause and cause-specific mortality coded through the International Statistical Classification 104 
of Diseases and Related Health Problems (10th revision). 105 
 106 
Statistics 107 
The normality of distribution for continuous data was checked with Shapiro-Wilk tests. As 108 
it was not verified for age, BMI, CIRS-score, phase angle, and standardized phase angle at the 109 
time of the last BIA measurement, the data were categorized into the followings: age as 65-74 110 
yrs, 75-84 yrs and ≥85 yrs; BMI as <18.5, 18.5-24.9, 25-29.9 and ≥30 kg/m2; CIRS score and 111 
standardized phase angle as quartiles; and phase angle as sex-specific quartiles. Quartile 1 112 
corresponded to the lowest phase angle values and was used as a reference category in 113 
subsequent analyses. Continuous data were compared between men and women or hospitalized 114 
and ambulatory people with Wilcoxon ran-sum u test, and ordinal data with Mann-Whitney U 115 
7 
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tests.  116 
Using univariate Cox regressions, we first evaluated the association of raw BIA-derived 117 
electrical parameters, such as quartiles, with mortality to verify whether phase angle is the best 118 
predictor of mortality among the measured electrical parameters. The multivariate included 119 
three Cox regressions models: the first two models used sex-specific phase angle quartiles 120 
(women: model 1; men: model 2) and were adjusted for age category, BMI category, CIRS 121 
quartile, and hospitalized vs. ambulatory state. The third Cox regression model used 122 
standardized phase angle quartiles adjusted only for CIRS quartiles and hospitalized vs. 123 
ambulatory state (model 3). To evaluate whether phase angle better predicts mortality than 124 
FFMI alone, we replaced the sex-specific phase angle quartiles in model 1 and 2 by sex-specific 125 
FFMI quartiles or added sex-specific FFMI quartiles. For each Cox regression model, we 126 
calculated hazards ratio (HRs) and their 95% CI, the adjusted R-squared (R2), and 95% CI with 127 
5000 bootstrap replications. R2 corresponds to the variance of mortality explained by each 128 
model and allows comparisons between the different Cox regression models. We tested the 129 
collinearity between predictor variables by calculating their variance inflation factor. The latter 130 
values were all below 10, indicating the absence of collinearity. We performed Kaplan-Meier 131 
analysis and calculated mortality trends according to sex-specific and standardized phase angle 132 
quartiles.  133 
To determine the discriminative ability of the phase angle, we computed receiver operating 134 
characteristic (ROC) curves predicting mortality from logistic models. These models included 135 
phase angle in women, phase angle in men or standardized phase angle as the only dependent 136 
continuous variable.  137 
Statistical analyses were run with Stata software version 13.1 (TX, USA). The limit of 138 
significance was set at p<0.05.  139 
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RESULTS 140 
We included 1307 people (38% women) whose characteristics at the last BIA measurement 141 
are shown in Table 1. The standardized phase angle was below -1SD in 919 (70%) people and 142 
below -2SD in 523 (40%) people. The cut-offs for the sex-specific phase angle quartiles, the 143 
standardized phase angle quartiles and the CIRS quartiles are shown in Table 2. Among the 144 
included people, 49% were measured in the hospital setting. Compared to ambulatory people, 145 
hospitalized women and men had a lower phase angle, were older and had more co-morbidities 146 
(Supplemental Table 1).  147 
Univariate Cox regression analyses showed that, on the basis of R2 (95%CI), phase angle 148 
was a better predictor of mortality than resistance, reactance, and impedance (Supplemental 149 
Table 2). The risk of mortality decreases as the phase angle or standardized phase angle 150 
quartiles increase in univariate (Table 3) and multivariate (Table 4) Cox regression models. 151 
When replacing sex-specific phase angle quartiles by sex-specific FFMI quartiles in models 1 152 
and 2, the R2 (95% CI) decreased from 15.6 (11.4, 27.2) to 8.6 (3.8, 16.5) in women and from 153 
21.5 (17.1, 29.2) to 14.2 (9.4, 20.2) in men. The addition of sex-specific FFMI quartiles to 154 
models 1 and 2 led to an R2 (95%CI) of 15.1 (11.7, 28.0) in women and 21.3 (17.4, 29.7) in 155 
men. Thus, the phase angle better predicts mortality than BIA-derived FFMI, and the addition 156 
of FFMI to phase angle does not improve the Cox regression models. Kaplan-Meier analyses 157 
showed the higher risk of mortality with lower phase angle (Supplemental figure 1) or 158 
standardized phase angle quartiles (Figure 1). Mortality trends are shown in Supplemental 159 
Table 3.  160 
The discriminative value of continuous phase angle, as assessed by the area under the ROC 161 
curve, was 0.72 (95% CI 0.67, 0.76) in women and 0.76 (95% CI 0.73, 0.79) in men while the 162 
discriminative value of continuous standardized phase angle amounted to 0.72 (95%CI 0.70, 163 
0.75). The best thresholds were 3.97 in women (sensibility and specificity 66%) and 4.38 in 164 
men (sensibility and specificity 68%) for continuous phase angle, and -1.41 for standardized 165 
9 
Published in final edited form as: Rejuvenation Res. 2017 Apr;20(2):118-124. doi: 10.1089/rej.2016.1879 
 
phase angle (sensibility and specificity 67%).  166 
10 
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DISCUSSION 167 
This study shows that phase angle or standardized phase angle quartiles predict mortality in 168 
older people, even when adjusted for co-morbidities or setting of measurement. Phase angle is 169 
a stronger predictor of mortality than other BIA-derived electrical parameters and BIA-derived 170 
FFMI. However, the discriminative ability of continuous phase angle or standardized phase 171 
angle is not good enough to perform individual predictions. This is supported by the fact that 172 
the dichotomization of phase angle or standardized phase angle by thresholds leads to a 173 
significant loss of predictive capacity. 174 
Few other articles have linked phase angle with mortality in older people unselected for their 175 
primary disease. Wirth et al. included 1071 patients aged >60 yrs who were admitted to an acute 176 
German geriatric hospital unit, mainly for heart failure, dementia or acute stroke (14). All BIA 177 
measurements were performed with a device of the same brand as in our study within 3 days of 178 
admission, and mortality was considered until the end of the hospital stay. They found a 179 
significantly lower phase angle in women than men (4.1±1.1° vs. 4.4±1.2°), but this gender 180 
difference disappeared after correction for age. The mortality risk was increased fourfold in 181 
patients with an age-corrected phase angle <3.5° vs. all other patients, although it was not 182 
adjusted for co-morbidities or BMI. No Cox regressions were performed. In our study, a value 183 
<3.5° corresponds to phase angle values of quartile 1. The mortality trends show that the risk 184 
of mortality decreases progressively with higher phase angle quartiles and is over 4 times higher 185 
in quartile 1 than in quartile 4. 186 
In another study, 4667 US ambulatory frail people aged >60 yrs underwent a phase angle 187 
measurement by a Valhalla device and were followed over 12 years (15). Cox regressions were 188 
performed for men and women separately and adjusted for age, ethnicity and five self-reported 189 
physician diagnosis (diabetes, chronic lung disease, chronic kidney disease, cardiovascular 190 
disease and arthritis). The mean phase angle was 6.3° in women and 6.7° in men. A phase angle 191 
value in the lowest quintile (2.7-5.4° in women, 3.1-5.6° in men) more than doubled the risk of 192 
11 
Published in final edited form as: Rejuvenation Res. 2017 Apr;20(2):118-124. doi: 10.1089/rej.2016.1879 
 
mortality compared to higher phase angle values. The association between phase angle and 193 
mortality was also found in people with limited or no co-morbidities at the time of BIA 194 
measurement. Thus, our study confirms that phase angle can be considered as a prognostic 195 
marker in a population of older people, as in both studies detailed above.  196 
The mean phase angle in our study was similar to the values of the aforementioned German 197 
study but was lower than in the American study. These differences may be related to the 198 
considered BIA device and the study population. Indeed, in people aged >70 yrs, the American 199 
reference values of phase angle measured by an RJL device were 5.6±1.0° in women and 200 
6.2±1.0° in men (23) while the German reference values, measured by a Data Input device, 201 
were 5.1±0.8° and 5.1±0.9° in normal-weight women and men, respectively (16). In order to 202 
overcome the problematic issue of device-dependent phase angles and in the absence of a gold 203 
standard method, we suggest that the phase angle values should preferentially be compared with 204 
the measurements performed with BIA devices of the same brand or cross-validated for phase 205 
angle. Comparisons of the phase angle between studies using different BIA devices require the 206 
calculation of a standardized phase angle (Z-score) through device-specific reference values. 207 
In view of this association between phase angle and mortality, the question arises whether 208 
there is a device-specific phase angle cut-off associated with an increased risk of mortality. In 209 
our study, the cut-offs maximizing sensitivity and sensibility was 3.97° in women and 4.38° in 210 
men or -1.41, when using standardized phase angle, but they were not good enough to perform 211 
individual predictions. Other studies using the same brand of BIA device as in our study 212 
evaluated this issue in specific diseases, such as cancer, HIV, and hemodialysis. In cancer 213 
patients, Norman et al. have suggested the use of a phase angle value corresponding to values 214 
below percentile 5 of the German sex-, age- and BMI-specific reference values as cut-offs (16). 215 
These values corresponded to a phase angle <3.9° and <3.8° in normal-weight women and men 216 
aged ≥70 yrs, respectively. They were related to a worse nutritional state, lower handgrip 217 
strength, peak expiratory flow and physical ability, more co-morbidities, and a higher risk of 218 
12 
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mortality (8) (24). An increased mortality risk has also been demonstrated with a phase angle 219 
≤3.9° in systemic sclerosis patients (25) and a phase angle <5.3° in HIV patients (11), but the 220 
cut-offs were arbitrarily determined. These results show that cut-offs relating absolute phase 221 
angle values with mortality have not yet been clearly defined, even when using a similar BIA 222 
device. Thus, it may be more useful to rely on the evolution of phase angle for prognosis 223 
assessment than on a single measurement. Interestingly, cross-sectional studies have shown that 224 
the mortality risk decreases by 36% and by over 50% for every 1° increase in phase angle in 225 
hemodialysis (13) and HIV patients (11), respectively.  226 
Whether using a standardized phase angle improves the predictive power of mortality 227 
remains questionable. In our study, we could not highlight any improvement as compared to 228 
the use of sex-specific absolute phase angle values. This may be related to the fact that we have 229 
considered sex- specific absolute phase angle in a population ≥ 65 years. Standardized phase 230 
angle may be a better predictor of mortality in study populations combining both sexes and of 231 
a larger age range.  In cancer patients, a standardized phase angle below -1.65, corresponding 232 
to values below percentile 5 of Brazilian Reference values, was associated with a higher weight 233 
loss (26) and mortality (27). Furthermore, a standardized phase angle below percentile 5 of 234 
German Reference values was reported to have a higher predictive power of mortality than 235 
malnutrition and disease severity (8).  236 
The originality of this study relies on the large sample of both hospitalized and ambulatory 237 
older people. Phase angle was associated with mortality even when taking into account many 238 
co-morbidities and subsequent treatments through the CIRS score. We could show that phase 239 
angle is a better predictor of mortality than BIA-derived FFMI, even though FFMI was 240 
measured by a locally validated BIA formula. As we focused on phase angle measurements 241 
performed with a BIA device for which reference values have been published, we could 242 
calculate the standardized phase angles. This allows comparisons with other studies that have 243 
standardized their phase angle through device-specific reference values. 244 
13 
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This study has several limitations. It is a retrospective and not a population-based study. We 245 
could not retrieve the co-morbidities for all patients. However, for patients with existing data, 246 
the information was based on medical discharge letters, which is likely more reliable than 247 
patient reports. We used the phase angle measurements performed with a single BIA device as 248 
this device was used to publish phase angle reference values in people living in Central Europe. 249 
Finally, despite the fact the phase angle is a strong predictor of mortality, we do not know yet 250 
how to influence it clinically in an older community-dwelling people. 251 
 252 
CONCLUSION 253 
This study confirms the association of phase angle and mortality in older patients unselected 254 
for their primary disease, although we could not define a cut-off useful for individual 255 
predictions. This result suggests the potential use of phase angle as a prognostic marker and as 256 
a tool for monitoring of therapeutic strategies. Future studies should cross-validate the phase 257 
angle values between devices of different brands or standardize their phase angle values through 258 
device-specific reference values, in order to allow comparisons of outcome between studies 259 
using different BIA devices.   260 
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Table 1: Characteristics of the included people at the time of the last BIA measurement (n=1307) 
 Women Men  
 n % Median (Interquartile range) n % Median (Interquartile range) P1 
Continuous        
Age at measurement, y 491 100 72.8 (10.0) 816 100 72.0 (9.2) 0.228 
Age at death, y 215 43.8 77.0 (10.7) 413 50.6 75.5 (10.6) 0.012 
Length of follow-up, y 491 100 2.2 (3.7) 816 100 1.7 (2.9) <0.001 
Body mass index, kg/m2 491 100 22.6 (7.0) 816 100 23.7 (5.9) 0.004 
Cumulative Illness Rating Scale 438 89.2 14.0 (9.0) 743 91.1 16.0 (9.0) <0.001 
Resistance, Ω 491 100 589.0 (148.0) 816 100 517.5 (119.0) <0.001 
Reactance , Ω 491 100 43.0 (17.0) 816 100 40.0 (16.0) <0.001 
Impedance , Ω 491 100 591.7 (147.4) 816 100 518.1 (118.6) <0.001 
Phase angle, degrees 491 100 4.1 (1.6) 816 100 4.4 (1.8) <0.001 
Standardized phase angle2 , degrees 491 100 -1.5 (1.7) 816 100 -1.3 (-2.0) 0.001 
Categorical        
Age, y       0.177 
65-74 297 60.5  523 64.1   
75-84 159 32.4  244 29.9   
≥85 35 7.1  49 6.0   
Body mass index, kg/m2       0.038 
<18.5 94 19.1  86 10.5   
18.5-24.9 223 45.4  416 51.0   
25.0-29.9 113 23.0  242 29.7   
≥30 61 12.4  72 8.8   
1 P: comparisons of continuous data were performed with Wilcoxon rank-sum test and of ordinal data with Mann-Whitney U-tests. 
2 Standardized phase angle = (observed phase angle-mean reference phase angle)/ SD of reference phase angle
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Table 2: Quartiles for phase angle, standardized phase angle and Cumulative Illness Rating 
Scale at the time of the last BIA measurement 
 n (%) Degrees 
Phase angle in women (n=491) 
Quartile 1 123 25.1 1.10, 3.33 
Quartile 2 123 25.1 3.34, 4.06 
Quartile 3 123 25.1 4.07, 4.89 
Quartile 4 122 24.9 4.90, 11.20 
Phase angle in men (n=816)    
Quartile 1 204 25.0 0.93, 3.53 
Quartile 2 204 25.0 3.54, 4.38 
Quartile 3 204 25.0 4.39, 5.33 
Quartile 4 204 25.0 5.34, 8.23 
Standardized phase angle1 (n=1307) 
Quartile 1 327 25.0 -5.54, -2.28 
Quartile 2 327 25.0 -2.27, -1.39 
Quartile 3 327 25.0 -1.38, -0.35 
Quartile 4 326 25.0 -0.34, 7.30 
Cumulative Illness Rating Scale (n=1181) 
Quartile 1 298 25.2 0, 10 
Quartile 2 326 27.6 11, 15 
Quartile 3 300 25.4 16, 20 
Quartile 4 257 21.8 21, 39 
1 Standardized phase angle = (observed phase angle-mean reference phase angle)/ SD of reference phase angle   
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Table 3: Univariate Cox regressions for phase angle and standardized phase angle quartiles  
 HR (95%CI) P R2 (95%CI) 
Phase angle in women (n=491)   21.6 (14.6, 30.9) 
Quartile 1 1.00   
Quartile 2 0.63 (0.45, 0.87) 0.005  
Quartile 3 0.41 (0.29, 0.59) <0.001  
Quartile 4 0.14 (0.08, 0.23) <0.001  
Phase angle in men (n=816)   24.4 (18.5, 31.1) 
Quartile 1 1.00   
Quartile 2 0.67 (0.53, 0.85) 0.001  
Quartile 3 0.42 (0.33, 0.55) <0.001  
Quartile 4 0.13 (0.08, 0.18) <0.001  
Standardized phase angle1 (n=1307 )   20.6 (16.1, 25.9) 
Quartile 1 1.00   
Quartile 2 0.67 (0.56, 0.82) <0.001  
Quartile 3 0.40 (0.33, 0.50) <0.001  
Quartile 4 0.16 (0.12, 0.22) <0.001  
1 Standardized phase angle = (observed phase angle-mean reference phase angle)/ SD of reference phase angle   
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Table 4: Multivariate Cox regression analyses (n=1181) 
 HR (95%CI) P R2 (95%CI) p 
Model 11 (n=438 women)   15.6 (11.4, 27.2) <0.001 
Phase angle quartile 1 1.00    
Phase angle quartile 2 0.69 (0.49, 0.97) 0.031   
Phase angle quartile 3 0.56 (0.37, 0.85) 0.006   
Phase angle quartile 4 0.30 (0.17, 0.53) <0.001   
Model 21 (n=743 men)   21.5 (17.1, 29.2) <0.001 
Phase angle quartile 1 1.00    
Phase angle quartile 2 0.81 (0.63, 1.04) 0.104   
Phase angle quartile 3 0.62 (0.47, 0.83) 0.001   
Phase angle quartile 4 0.37 (0.23, 0.57) <0.001   
Model 32 (n=1181)    17.0 (13.4, 22.3) <0.001 
Standardized phase angle3 quartile 1 1.00    
Standardized phase angle3 quartile 2 0.71 (0.58, 0.86) 0.001   
Standardized phase angle3 quartile 3 0.53 (0.42, 0.67) <0.001   
Standardized phase angle3 quartile 4 0.32 (0.23, 0.43) <0.001   
1Adjusted for age category, BMI category, Cumulative Illness Rating Scale quartile, hospitalized vs. ambulatory 
state 
2 Adjusted for Cumulative Illness Rating Scale quartiles, hospitalized vs. ambulatory state 
3 Standardized phase angle = (observed phase angle-mean reference phase angle)/ SD of reference phase angle 
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FIGURE 
 
Figure 1: This figure shows the Kaplan-Meier analysis for standardized phase angle (sPA) 
quartiles. The curves are significantly different between phase angle quartiles (logrank test 
p<0.001). 
 
